Skip to content

Clinical trials

Phase 4 Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 4 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20075
20082
20101
20124
20141
20181
20191
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Unknown status4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eyetech Pharmaceuticals3
David M. Brown, M.D.2
Formycon AG2
Illinois Retina Associates2
Tennessee Retina2
University of California, San Diego2
Bausch & Lomb Incorporated1
Brandon G. Busbee, MD1
California Retina Consultants1
Harrow Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration23
Diabetic Retinopathy4
Retinal Vein Occlusion3
Choroidal Neovascularization2
Wet Macular Degeneration2
Endophthalmitis1
Neovascularization, Pathologic1
Retinal Degeneration1
Retinal Detachment1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.